tiprankstipranks
TipRanksTop Financial ExpertsInsidersEdward Kaye

Edward Kaye Insider Profile

18 Followers
Edward Kaye, Director at Sarepta Therapeutics, holds 10.37K shares in Cytokinetics (Ticker: CYTK), holds 110.87K shares in Stoke Therapeutics (Ticker: STOK), holds 0.00 shares in Avidity Biosciences (Ticker: RNAM).
See the Hottest Stocks Based on Insider Trading >
tipranks
Edward Kaye

Edward Kaye
Sarepta Therapeutics (SRPT)
Director

Ranked #104,408 out of 107,049 Corporate Insiders

Profitable Transactions

10%
1 out of 10 Profitable Transactions

Average Return

-85.40%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark
How are Insiders Ranked?

Insider Holdings

$6M
62.79%
25.74%
11.48%
A breakdown of Edward Kaye's holdings
See the Top Stocks by Insiders

Insider Roles

Stoke Therapeutics
(STOK)
Director
Sarepta Therapeutics
(SRPT)
Director
Cytokinetics
(CYTK)
Director
Roles that Edward Kaye holds in companies
See the Top Corporate Insiders

Most Profitable Insider Trade

Stock:
Cytokinetics
(CYTK)
Rating:Informative Sell
Date:Nov 12, 2025 - Today
Return:+0.90%
The most profitable trade made by Edward Kaye
See the Latest Stocks Traded by Insiders

Edward Kaye's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
SRPT
Sarepta Therapeutics
Aug 07, 2017
Director
Uninformative Buy
710.55K
$1.49M
CYTK
Cytokinetics
Apr 15, 2026
Director
Uninformative Buy
12.49K
$663.05K
STOK
Stoke Therapeutics
Mar 17, 2026
Director
Uninformative Buy
2.05M
$3.63M
RNAM
Avidity Biosciences
Feb 27, 2026
―
Uninformative Sell
―
$0.00
List of latest transactions for each holding click on a transaction to see Edward Kaye's performance on stock
See All Insider Trading from Today

You May Also Like

Meet our Smart Portfolio. See what top analysts say about your stocks.Get a breakdown of the different strategies based on detected insider trading activity.Find the best performing Analyst in each sector. Follow them so you never miss a recommendation.

Edward Kaye insider profile FAQ

What is the percentage of profitable transactions made by Edward Kaye?
The percentage of profitable transactions made by Edward Kaye is 10%.
    What is the average return per transaction made by Edward Kaye?
    The average return per transaction made by Edward Kaye is -85.40%.
      What stocks does Edward Kaye hold?
      Edward Kaye holds: SRPT, CYTK, STOK, RNAM stocks.
        What was Edward Kaye’s latest transaction?
        Edward Kaye latest transaction was an Uninformative Buy of $12.49K.
          What was Edward Kaye's most profitable transaction?
          Edward Kaye’s most profitable transaction was an Informative Sell of CYTK stock on November 12, 2025. The return on the trade was 0.90%.
            What is Edward Kaye's role in Sarepta Therapeutics?
            Edward Kaye's role in Sarepta Therapeutics is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.